Vaccinium arctostaphylos fruit on levels of inflammatory factors in adult patients with hyperlipidemia

Evaluation of the effect of Vaccinium arctostaphylos fruit alcoholic extract on serum levels of inflammatory factors in adult patients with hyperlipidemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201507309662N10

Enrollment

Registered

2015-09-16

Start date

2015-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pure hypercholesterolaemia. Condition 2: Hyperlipidaemia, unspecified. Condition 3: Other disorders of lipoprotein metabolism. Pure hypercholesterolaemia Hyperlipidaemia, unspecified Other disorders of lipoprotein metabolism

Interventions

Intervention 1: control group: take placebo capsol twice a day for a month. Intervention 2: case group: take Vaccinium arctostaphylos capsol twice a day for a monthr.

Placebo

Treatment - Drugs

control group: take placebo capsol twice a day for a month

case group: take Vaccinium arctostaphylos capsol twice a day for a monthr

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion/exclusion criteria: age over of 18 years; serum levels of total cholesterol 200–300 mg/dL and/or triglyceride (TG) 150–199 mg/dL and/or LDL-C 130 130–190 mg/dL; being non-smokers; free of diseases affecting serum lipids (e.g., diabetes, thyroid disorders, and pancreatitis); not using drugs or supplements affecting serum lipids (e.g., statins, fibrate derivatives, estrogens, progestins, beta-blockers, thiazide diuretics, and fish oil) within the last 3 months; free of liver or kidney disease; nonpregnant, nonlactating women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intercellular adhesion molecule-1. Timepoint: Before and after one Month. Method of measurement: ELISA Kit.;Vascular cell adhesion molecule-1. Timepoint: Before and after one Month. Method of measurement: ELISA Kit.;IL-6. Timepoint: Before and after one Month. Method of measurement: ELISA Kit.;TNF-a. Timepoint: Before and after one Month. Method of measurement: ELISA Kit.	—

Secondary

Measure	Time frame
Weight. Timepoint: Before and after 4 weeks. Method of measurement: scale.;Creatinine level. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Urea levels. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Liver enzyme ALT. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Liver enzyme AST. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.	—

Measure

Time frame

Weight. Timepoint: Before and after 4 weeks. Method of measurement: scale.;Creatinine level. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Urea levels. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Liver enzyme ALT. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.;Liver enzyme AST. Timepoint: Before and after One Month. Method of measurement: ELISA Kit.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026